Interscalene Block vs Serratus Posterior Superior Intercostal Plane Block

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorMedipol University

About this trial

Postoperative pain is important following arthroscopic shoulder surgery. Postoperative effective pain treatment provides early mobilization and a shorter hospital stay. Ultrasound (US)-guided brachial plexus blocks, such as interscalene and supraclavicular block, are usually performed. Interscalen brachial plexus block (ISCB) is one of the most preferred techniques among these.

Ultrasound (US) guided serratus posterior superior block (SPSPB) is a new interfacial plane block defined by Tulgar et al in 2023. It is based on injection on the serratus posterior superior muscle at the level of the 2nd or 3rd rib. This block provides analgesia in conditions such as interscapular pain, chronic myofascial pain syndromes, scapulocostal syndrome, and shoulder pain. The SPS muscle is located at the C7-T2 level. It attaches to the lateral edges of the second and fifth ribs. It is innervated by the lower cervical and upper intercostal nerves. With the SPS block, these nerves are blocked, and analgesia is provided. It has been reported that SPSIPB provides effective analgesia after shoulder surgery.

The aim of this study is to compare the efficacy of the US-guided SPSIPB and ISCB for postoperative analgesia management after arthroscopic shoulder surgery.

Eligibility criteria

Qualifiers

American Society of Anesthesiologists (ASA) classification I-II

Scheduled for arthroscopic shoulder surgery under general anesthesia

Disqualifiers

history of bleeding diathesis,

receiving anticoagulant treatment,

known local anesthetics and opioid allergy,

infection of the skin at the site of the needle puncture,

Trial design

Treatments tested in this trial

  • Erector spinae plane block
  • Serratus posterior superior intercostal plane block
  • Postoperative analgesia management

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators